Search Results
TCT 23: Four-Year Outcomes from the EVOLUT Low Risk Trial
TCT 23: 5Y Outcomes From the PARTNER 3 Low-Risk Trial
Overview of PARTNER 3 & Evolut Low Risk TAVR Trials
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
View from the Thoraxcenter: TCT 23 Late-breaking Science Preview
TCT 23: 5 Trials That Will Change My Practice with Dr Mirvat Alasnag
TCT 23: 5 Trials That Changed My Practice with Dr Kendra Grubb
TCT 23: AGENT IDE: AGENT Paclitaxel Coated Balloon Angioplasty for In-Stent Restenosis
TCT 23: 5 Trials That Will Change My Practice
TRISCEND II: Transcatheter tricuspid valve replacement in patients with severe TR
Tuesday, October 24 | ACCess Points Daily Wrap Up at TCT 2023
AQVA-II Trial | TCT 2023
